PROCEPT BioRobotics (PRCT) Current Assets (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Current Assets data on file, last reported at $428.0 million in Q1 2026.

• Quarterly Current Assets fell 8.11% year-over-year to $428.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $428.0 million (down 8.11% YoY) and the FY2025 annual result came in at $450.4 million, down 6.53% from the prior year.
• Current Assets fell to $428.0 million in Q1 2026 per PRCT's latest filing, from $450.4 million in the prior quarter.
• Across five years, Current Assets topped out at $481.8 million in Q4 2024 and bottomed at $230.0 million in Q2 2023.
• The 5-year median for Current Assets is $329.2 million (2024), against an average of $357.4 million.
• The widest annual swing landed in 2023, when Current Assets retreated 22.9%; it then jumped 42.3% in 2025.
• Tracing PRCT's Current Assets over 5 years: stood at $272.6 million in 2022, then increased by 28.59% to $350.6 million in 2023, then soared by 37.45% to $481.8 million in 2024, then dropped by 6.53% to $450.4 million in 2025, then dropped by 4.96% to $428.0 million in 2026.
• Per Business Quant, the three latest PRCT Current Assets figures stand at $428.0 million (Q1 2026), $450.4 million (Q4 2025), and $454.8 million (Q3 2025).

Peer Comparison